Leveraging ADME Test Systems to De-risk CGT Studies

Conventional in vitro ADME test systems can play a very useful role in CGT development, helping to identify potential safety issues early. These assays will likely become even more important as scientists endeavor to treat larger patient populations for multi-genetic diseases that might be controlled with several conventional medications and lifestyle changes. Visit the link below to learn more about challenges in gene therapy research, and how ADME test systems can be repurposed in CGT development.